Delivery Order SPE2DB22D1017-SPE2DB24FG0HH
- Not listed
- This federal contract was awarded to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA) for the delivery of NovologTM 100 Unit/mL FlexPenTM 3mL, a common insulin delivery device. The $2,097.12 delivery order contract is a firm fixed-price arrangement with an ultimate completion date of June 18, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical as the...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The $3,676.32 delivery order contract is for the supply of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a type of insulin medication. The contract has a firm fixed price pricing type and a period of performance extending through May 30, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,403.08 firm fixed-price delivery order is for the supply of NovologTM 100 unit/mL FlexPen 3mL, a prescription insulin product. The contract has an ultimate completion date of November 6, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of NovologⓇ 100 Unit/mL FlexPenⓇ 3mL insulin pens. The $1,089.28 firm fixed-price delivery order was placed by the Defense Logistics Agency, a defense agency, and has a completion date of June 5, 2024. The award is not associated with a set-aside program. Amerisourcebergen is a major pharmaceutical distributor that holds a $999,999,999.00 single-award Indefinite Delivery Contract with DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Novolog 100 Unit/mL Flexpen 3mL insulin pens. The contract has a ceiling value of $3,111.20 and a period of performance through May 31, 2024. It is a firm fixed price delivery order contract, without any set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 with...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a firm fixed price delivery order for the provision of NovologTM 100 unit/mL FlexPen 3mL. The award, valued at $1,420.64, was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense, and has a performance period through March 26, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA Troop Support...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of NovOlog 100 unit/mL FlexPen 3mL, a type of insulin delivery device. The $1,092.43 firm-fixed price contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation. Amerisourcebergen, a large pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical as the primary...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of NovologTM 100 Unit/mL FlexPenTM 3mL insulin syringes. The $1,225.44 Firm Fixed Price contract is a Delivery Order awarded by the Defense Logistics Agency (DLA), a defense agency. There is no set-aside designation, indicating open competition. The contract has an ultimate completion date of December 7, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract...
- This federal contract award to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, is for the delivery of NovologTM 100 unit/mL FlexPen 3mL, a brand name insulin product. The $2,700.27 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA) under an indefinite delivery contract (IDC) with a potential value of $999,999,999.00. This IDC serves as the primary contract vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was issued by the Defense Logistics Agency (DLA) for the delivery of NOVOLOG 100 UNIT/ML FLEXPEN 3ML medical supplies. The firm-fixed-price delivery order, valued at $1,054.35, has an ultimate completion date of February 24, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB24FG0HHDelivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of NovologTM 100 unit/mL Flexpen 3mL insulin products. The $1,703.48 firm-fixed-price contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of June 28, 2024. The contract is not set aside for any specific business type. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This specific order falls under that broader IDC vehicle. Amerisourcebergen also holds a smaller $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 6/27/24 |